Keyword: Teva CEO Shlomo Yanai
News
04.05.2011
- Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...
News
28.03.2011
- Procter & Gamble and generic drugmaker Teva Pharmaceutical Industries are joining forces to sell over-the-counter medicines as both companies try to expand their reach...
